Pernix Therapeutics Holdings, Inc.

NASDAQ: PTXHealthcare / Drug Manufacturers - Other / USA
0.2100-0.0100-4.55%Vol 1 010 5001Y Perf -92.76%
Mar 4th, 2019 00:00
BID0.0000 ASK0.0000
Open0.2200 Previous Close0.2200
Pre-Market- After-Trading-
 - -%  - -%
Target Price
3.00 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)3 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.00 
Earnings Date
14th Mar 2019

Today's Price Range

0.20000.2400

52wk Range

0.20003.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-
1 Month
-
3 Months
0.00%
6 Months
-47.50%
1 Year
-92.76%
3 Years
-95.96%
5 Years
-99.75%
10 Years
-99.17%

Name / TickerPriceChg.Chg.%
PTX0.2100-0.0100-4.55
AAPL202.59-3.0700-1.49
GOOG1 130.10-16.2300-1.42
MSFT136.620.20000.15
XOM74.990.15000.20
WFC46.030.21000.46
JNJ130.31-1.7600-1.33
FB198.36-2.4200-1.21
GE10.04-0.0200-0.20
JPM113.54-1.1300-0.99
Earnings HistoryEstimateReportedSurprise %
Q04 2017--2.78-
Q04 2016--3.86-
Q03 2016--2.73-
Q02 2016-0.50-4.90-880.00
Q01 20160.00-3.50-
Q04 2015-0.20-5.90-2 850.00
Q03 20150.100.80700.00
Q02 2015-0.10-1.00-900.00
Earnings Per EndEstimateRevision %Trend
12/2016 FY-3.700.00-
12/2017 FY0.100.00-
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 010 500
Shares Outstanding (in ths.)14 506
Trades Count1 371
Dollar Volume210 624
Avg. Volume2 010 779
Avg. Weekly Volume2 432 120
Avg. Monthly Volume4 012 120
Avg. Quarterly Volume1 901 514
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating---

CEO:

Teplephone:

Address: , , ,

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

64%36%

News